Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 18, 2025, 3:59 PM
1.30
-2.62%
After-hours: Aug 18, 2025, 07:48 PM EDT
Evogene Revenue
Evogene reported an annual revenue of $8.51M, reflecting a 50.9% growth. For the quarter ending March 31, 2025, Evogene generated $2.44M in revenue.
Revenue (ttm)
8.51M
Revenue Growth
50.9%
Price / Sales Ratio
1.25
Revenue / Employee
72.74K
Employees
117
Market Cap
11.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 8.51M | +50.90% |
| Dec 31, 2023 | 5.64M | +236.72% |
| Dec 31, 2022 | 1.68M | +80.11% |
| Dec 31, 2021 | 930K | -10.58% |
| Dec 31, 2020 | 1.04M | +38.11% |
| Dec 31, 2019 | 753K | -56.90% |
| Dec 31, 2018 | 1.75M | -48.33% |
| Dec 31, 2017 | 3.38M | -48.30% |
| Dec 31, 2016 | 6.54M | -41.23% |
| Dec 31, 2015 | 11.13M | -23.31% |
| Dec 31, 2014 | 14.51M | -17.46% |
| Dec 31, 2013 | 17.58M | +2.98% |
| Dec 31, 2012 | 17.07M | +14.57% |
| Dec 31, 2011 | 14.9M | n/a |